T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
MBIA
MBI
$258M
| $411K | ﹤0.01% |
43,050
-7,700
| -15% | -$74.3K |
|
2027
Yelp
YELP
$1.28B
| $410K | ﹤0.01% |
7,500
| – | – |
|
|
RGC
2028
DELISTED
Regal Entertainment Group
RGC
| $410K | ﹤0.01% |
19,190
-3,900
| -17% | -$82.2K |
|
|
GES
2029
DELISTED
Guess Inc
GES
| $409K | ﹤0.01% |
19,420
-77,800
| -80% | -$1.66M |
|
2030
Rambus
RMBS
$10.9B
| $409K | ﹤0.01% |
36,900
| – | – |
|
2031
Old National Bancorp
ONB
$10.3B
| $407K | ﹤0.01% |
27,343
| – | – |
|
2032
Scansource
SCSC
$1.06B
| $406K | ﹤0.01% |
10,100
-3,900
| -28% | -$146K |
|
2033
German American Bancorp
GABC
$1.92B
| $405K | ﹤0.01% |
19,895
| – | – |
|
|
AF
2034
DELISTED
Astoria Financial Corporation
AF
| $404K | ﹤0.01% |
30,221
| – | – |
|
2035
Kulicke & Soffa
KLIC
$5.05B
| $400K | ﹤0.01% |
27,660
| – | – |
|
|
FSP
2036
Franklin Street Properties
FSP
$46.5M
| $399K | ﹤0.01% |
32,500
| – | – |
|
2037
Cathay General Bancorp
CATY
$4.31B
| $398K | ﹤0.01% |
15,556
| – | – |
|
2038
City Holding Co
CHCO
$2.07B
| $398K | ﹤0.01% |
8,550
| – | – |
|
2039
iShares MSCI Australia ETF
EWA
$1.45B
| $397K | ﹤0.01% |
17,900
+7,000
| +64% | +$166K |
|
2040
PENN Entertainment
PENN
$2.52B
| $397K | ﹤0.01% |
28,944
+8,130
| +39% | +$105K |
|
|
ZNGA
2041
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $396K | ﹤0.01% |
148,916
+2,500
| +2% | +$6.32K |
|
2042
Rogers Corp
ROG
$2.47B
| $395K | ﹤0.01% |
4,850
| – | – |
|
|
SYKE
2043
DELISTED
SYKES Enterprises Inc
SYKE
| $395K | ﹤0.01% |
16,840
| – | – |
|
|
OUTR
2044
DELISTED
OUTERWALL INC
OUTR
| $395K | ﹤0.01% |
5,250
-1,000
| -16% | -$64.1K |
|
2045
UMB Financial
UMBF
$11.4B
| $393K | ﹤0.01% |
6,912
+304
| +5% | +$17.1K |
|
|
GTIV
2046
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $391K | ﹤0.01% |
20,525
-9,000
| -30% | -$172K |
|
2047
Lattice Semiconductor
LSCC
$18.3B
| $390K | ﹤0.01% |
56,600
+11,100
| +24% | +$72.9K |
|
2048
V2X
VVX
$2.53B
| $390K | ﹤0.01% |
+14,227
| New | +$361K |
|
2049
Metallus
MTUS
$896M
| $389K | ﹤0.01% |
10,500
| – | – |
|
2050
Benchmark Electronics
BHE
$2.94B
| $386K | ﹤0.01% |
15,175
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.